AnaptysBio Inc buy Guggenheim
Start price
06.05.25
/
50%
€17.50
Target price
06.05.26
€47.81
Performance (%)
127.43%
Price
29.01.26
€39.80
Summary
This prediction is currently active. The BUY prediction by Guggenheim for AnaptysBio Inc has seen massive gains of 127.43%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -1.500% | -1.500% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $52.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat